255 related articles for article (PubMed ID: 24531780)
1. Phase III prostate cancer chemoprevention trials.
Parnes HL; Brawley OW; Minasian LM; Ford LG
Recent Results Cancer Res; 2014; 202():73-7. PubMed ID: 24531780
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer prevention: strategies for agent development.
Parnes HL; House MG; Tangrea JA
Curr Opin Oncol; 2013 May; 25(3):242-51. PubMed ID: 23518594
[TBL] [Abstract][Full Text] [Related]
3. A review of phase III clinical trials of prostate cancer chemoprevention.
Thorpe JF; Jain S; Marczylo TH; Gescher AJ; Steward WP; Mellon JK
Ann R Coll Surg Engl; 2007 Apr; 89(3):207-11. PubMed ID: 17394699
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention of prostate cancer: an updated view.
Klein EA; Thompson IM
World J Urol; 2012 Apr; 30(2):189-94. PubMed ID: 22238120
[TBL] [Abstract][Full Text] [Related]
5. Is There a Future for Chemoprevention of Prostate Cancer?
Bosland MC
Cancer Prev Res (Phila); 2016 Aug; 9(8):642-7. PubMed ID: 27099271
[TBL] [Abstract][Full Text] [Related]
6. Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancer.
Kim J; Sun P; Lam YW; Troncoso P; Sabichi AL; Babaian RJ; Pisters LL; Pettaway CA; Wood CG; Lippman SM; McDonnell TJ; Lieberman R; Logothetis C; Ho SM
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1697-702. PubMed ID: 16030104
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer chemoprevention.
Sandhu GS; Nepple KG; Tanagho YS; Andriole GL
Semin Oncol; 2013 Jun; 40(3):276-85. PubMed ID: 23806493
[TBL] [Abstract][Full Text] [Related]
8. Update on prostate cancer chemoprevention.
Lowe JF; Frazee LA
Pharmacotherapy; 2006 Mar; 26(3):353-9. PubMed ID: 16503715
[TBL] [Abstract][Full Text] [Related]
9. Risk adapted chemoprevention for prostate cancer: an option?
Schmitz-Dräger BJ; Schöffski O; Marberger M; Sahin S; Schmid HP
Recent Results Cancer Res; 2014; 202():79-91. PubMed ID: 24531781
[TBL] [Abstract][Full Text] [Related]
10. The future of prostate cancer prevention.
Brawley OW; Barnes S; Parnes H
Ann N Y Acad Sci; 2001 Dec; 952():145-52. PubMed ID: 11795434
[TBL] [Abstract][Full Text] [Related]
11. Can we prevent prostate cancer? Rationale and current status of prostate cancer chemoprevention.
Fujimoto N; Chang C; Nomura M; Matsumoto T
Urol Int; 2005; 74(4):289-97. PubMed ID: 15897691
[TBL] [Abstract][Full Text] [Related]
12. [Role of 5 alpha-reductase inhibitors in the chemoprevention of prostate cancer].
An C; Xu T; Wang XF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Oct; 33(5):582-6. PubMed ID: 22338147
[TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of prostate cancer by diet-derived antioxidant agents and hormonal manipulation (Review).
Pathak SK; Sharma RA; Mellon JK
Int J Oncol; 2003 Jan; 22(1):5-13. PubMed ID: 12469179
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of prostate cancer.
Thompson IM; Tangen CM; Goodman PJ; Lucia MS; Klein EA
J Urol; 2009 Aug; 182(2):499-507; discussion 508. PubMed ID: 19524966
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer chemoprevention: current status and future prospects.
Gupta S
Toxicol Appl Pharmacol; 2007 Nov; 224(3):369-76. PubMed ID: 17189645
[TBL] [Abstract][Full Text] [Related]
16. Clinical models for testing chemopreventative agents in prostate cancer and overview of SELECT: the Selenium and Vitamin E Cancer Prevention Trial.
Klein EA
Recent Results Cancer Res; 2003; 163():212-25; discussion 264-6. PubMed ID: 12903856
[TBL] [Abstract][Full Text] [Related]
17. Review of vitamin E and selenium in the prevention of prostate cancer: implications of the selenium and vitamin E chemoprevention trial.
Pak RW; Lanteri VJ; Scheuch JR; Sawczuk IS
Integr Cancer Ther; 2002 Dec; 1(4):338-44. PubMed ID: 14664728
[TBL] [Abstract][Full Text] [Related]
18. What's new in the field of prostate cancer chemoprevention?
Mahal K; Hernandez J; Basler JW; Thompson IM
Curr Oncol Rep; 2004 May; 6(3):237-42. PubMed ID: 15066236
[TBL] [Abstract][Full Text] [Related]
19. 5-Alpha reductase inhibitors in active surveillance.
Richard PO; Finelli A
Curr Opin Urol; 2014 May; 24(3):324-8. PubMed ID: 24710052
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of prostate cancer.
Klein EA
Annu Rev Med; 2006; 57():49-63. PubMed ID: 16409136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]